Act4GPP
The ‘Act4GPP’ initiative aims to support patients diagnosed with Generalised Pustular Psoriasis (GPP) and help them to feel connected and supported whilst navigating their disease journey. Our mission is to inform and motivate patients to speak to their doctor in order to better understand their diagnosis, disease and their options. The website is an initiative of Boehringer Ingelheim, a company with a longstanding commitment to improving the lives of people living with devastating diseases, including those affected by rare diseases.